NEI-funded Research in the News
October 31, 2013
Our vision depends on exquisitely organized layers of cells within the eye's retina, each with a distinct role in perception. Johns Hopkins researchers say they have taken an important step toward understanding how those cells are organized to produce what the brain "sees."
October 23, 2013
A promising technique for treating human eye disease has proven effective in preclinical studies and may lead to new treatments to prevent blindness, according to experiments conducted at The Scripps Research Institute (TSRI) in La Jolla, California.
October 16, 2013
Researchers report "encouraging" findings that mark the first clear step in developing a gene therapy that could prevent vision loss or even restore vision in individuals with Best disease.
October 9, 2013
The research findings, published today in PLOS ONE, are the first to report successful topical use of a compound capable of inhibiting symptoms associated with both dry AMD (the earlier form) and wet AMD (the rarer, later form) and could represent a breakthrough for treatment of these conditions.
August 21, 2013
Johns Hopkins biomedical engineers have teamed up with clinicians to create a new drug-delivery strategy for a type of central vision loss caused by blood vessel growth at the back of the eye, where such growth should not occur.
August 21, 2013
Retinal diseases are the leading cause of blindness in adults aged 60 and over, affecting millions of people worldwide. Pioneering research at the Levine Laboratory, Moran Eye Center, University of Utah is providing scientists with a new understanding of how the retina develops from conception to birth.
August 13, 2013
Scientists are developing a clearer picture of how visual systems develop in mammals. The findings offer important clues to the origin of retinal disorders later in life.
August 08, 2013
A new discovery by a University of Maryland-led research team offers hope for treating "lazy eye" and other serious visual problems that are usually permanent unless they are corrected in early childhood.
July 18, 2013
Researchers at Washington University School of Medicine in St. Louis and St. Jude Children's Research Hospital in Memphis have found that good vision depends, at least in part, on a recycling process in the eye that mops up cellular debris and reuses light-sensitive proteins.
May 20, 2013
Over the millennia of human evolution, our brains developed a pattern of search based largely on environmental cues and scene context.
May 8, 2013
For the first time, vision scientists at the University of California, Berkeley, have pinpointed how the brain tracks fast-moving objects.
April 22, 2013
When we embark on a targeted search, various visual and non-visual regions of the brain mobilize to track down a person, animal or thing.
April 9, 2013
Researchers have discovered that using two kinds of therapy in tandem may be a knockout combo against inherited disorders that cause blindness.
March 25, 2013
A 20-year study of almost 5,000 residents of Beaver Dam, Wis. has some good news - the eye health of older Americans is improving.
December 12, 2012
The odds of individuals with open-angle glaucoma undergoing visual field testing decreased for all racial/ethnic groups from 2001 through 2009, but the odds decreased the most for Hispanic men and women in a study of enrollees in a large U.S. managed care network.
December 10, 2012
For the first time, University of Wisconsin researchers have taken skin from patients and, using induced pluripotent stem cell technology, turned them into a laboratory model for an inherited type of macular degeneration.
December 7, 2012
Working with mice, Johns Hopkins researchers have shed light on the activity of a protein pair found in cells that form the walls of blood vessels in the brain and retina, experiments that could lead to therapeutic control of the blood-brain barrier and of blood vessel growth in the eye.
December 5, 2012
Researchers at the University of Illinois at Chicago and the University of California at Los Angeles recently created a light-sensitive molecule that they say could help restore vision lost in degenerative eye diseases, such as macular degeneration, and reduce epileptic seizures.
November 27, 2012
A substance in rosemary may have clinical applications for diseases affecting the retina, including age-related macular degeneration, U.S. researchers say. Dr. Stuart A. Lipton and colleagues at Sanford-Burnham Medical Research Institute said carnosic acid, a component of the herb rosemary, promotes eye health.
November 27, 2012
"Our findings are epigenetic in nature, meaning that the underlying DNA is normal but gene expression has been modified, likely by environmental factors, in an adverse way," Dr. Robert Nussenblatt, chief of the National Eye Institute Laboratory of Immunology, part of the National Institutes of Health, said in a statement.
November 21, 2012
Using a new technique called cryo-electron tomography, two research teams at Baylor College of Medicine have created a three-dimensional map that gives a better understanding of how the architecture of the rod sensory cilium (part of one type of photoreceptor in the eye) is changed by genetic mutation and how that affects its ability to transport proteins as part of the light-sensing process.
November 15, 2012
Researchers at Sanford-Burnham Medical Research Institute have found a way to stimulate stem cell-derived neurons to direct cognitive function after transplantation to an existing neural network by using optogenetic stimulation - getting us a step closer to using these cells to treat Alzheimer's disease and other neurodegenerative conditions.
November 14, 2012
Chemists and vision scientists at the University of Illinois at Chicago have designed a light-sensitive molecule that can stimulate a neural response in cells of the retina and brain -- a possible first step to overcoming degenerative eye diseases like age-related macular degeneration, or to quieting epileptic seizures.
November 9, 2012
Dr. Ronald Klein, of the University of Wisconsin School of Medicine and Public Health, and colleagues describe the relationship of age and risk alleles (variant gene forms) with the incidence and progression of age-related macular degeneration (AMD) during a 20-year period. They conclude the overall five-year incidence of early AMD was 9.1 percent and late AMD was 1.6 percent.